BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tandon P, Lee EY, Maxwell C, Hitz L, Ambrosio L, Dieleman L, Halloran B, Kroeker K, Huang VM. Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2021;66:1639-49. [PMID: 32533542 DOI: 10.1007/s10620-020-06381-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Prentice R, Wright EK, Flanagan E, Ross AL, Bell SJ. The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy. Inflamm Bowel Dis 2021:izab214. [PMID: 34751772 DOI: 10.1093/ibd/izab214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Leung KK, Huang V. Editorial: pregnancy and the gastroenterologist. Aliment Pharmacol Ther 2020;52:877-8. [PMID: 32852813 DOI: 10.1111/apt.15977] [Reference Citation Analysis]
3 Nuñez F P, Quera R, Sepúlveda E, Simian D, Pizarro G, Lubascher J, Flores L, Ibañez P, Figueroa C, Kronberg U. Pregnancy in Inflammatory Bowel Disease: Experience of a Chilean cohort. Gastroenterol Hepatol 2021;44:277-85. [PMID: 33745519 DOI: 10.1016/j.gastrohep.2020.08.005] [Reference Citation Analysis]